You are here

MenABCWY

5 FDA decisions to watch in the first quarter of 2025

BioPharma Dive

Mon, 01/6/25 - 06:54 pm

Vertex Pharmaceuticals

non-opioid pain treatments

transthyretin amyloid cardiomyopathy

diazoxide choline

Prader Willi syndrome

FDA accepts BLA for Pfizer’s meningococcal vaccine candidate

Pharmaceutical Business Review

Fri, 12/30/22 - 10:36 am

meningococcal disease

Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine

Endpoints

Thu, 09/15/22 - 10:31 am

meningococcal disease

clinical trials

GSK to overtake Sanofi atop meningococcal vaccine market, report predicts

Fierce Pharma

Wed, 06/8/16 - 03:12 pm

meningococcal disease